Clinical Efficacy of Chelation Therapy in Patients with Low-Risk Myelodysplastic Syndrome

The present literature review provides evidence that in patients with low-risk myelodysplastic syndrome and transfusion dependence blood parameters and survival rates can be improved by administration of iron chelators. Dose adequacy and therapy duration underlie clinical efficacy of chelators. Toxi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sergei Vasil’evich Gritsaev, I. I. Kostroma, A. A. Zhernyakova
Formato:	Artigo
Idioma:	Russo
Publicado em:	Practical Medicine Publishing House 2019-04-01
coleção:	Клиническая онкогематология
Assuntos:	myelodysplastic syndrome low risk transfusion dependence iron chelators survival
Acesso em linha:	https://bloodjournal.ru/index.php/coh/article/view/303
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!